Preliminary studies point out conolidine may inhibit certain ion channels, decreasing neuronal excitability and limiting pain indicators. This system is particularly related in neuropathic pain, where by abnormal signaling will cause persistent discomfort. Also, conolidine seems to impact G protein-coupled receptor (GPCR) pathways integral to pain perception. Computational docking https://margaretp369tqo0.wizzardsblog.com/profile